InCred Asset Management is cautious about US-facing generic pharma companies due to potential tariff risks and single-digit earnings growth. They favor domestic pharma companies with strong brands and ...

June 2025 fiscal flows signal short-term caution and likely SPX declines in July, but liquidity unlocks and Fed rate cuts ...

ICAI issues Guidance Note for non-corporate financial statements, effective April 1, 2024, replacing 2022 Technical Guide with standard ...